IP Group completes partial realisation in ONT

|
FOR RELEASE ON |
02 October 2026
|
IP Group completes c.£21m partial realisation in Oxford Nanopore
IP Group plc ("IP Group" or the "Group") (LSE: IPO), which invests in breakthrough science and technology companies with the potential to create a better future for all, announces that it has completed a partial realisation of its holding in Oxford Nanopore Technologies plc ("Oxford Nanopore" or the "Company").
IP Group has sold 10,000,000 ordinary shares in Oxford Nanopore (the "Sale"), generating gross proceeds of c.£21m. Following completion of the Sale, IP Group remains one of Oxford Nanopore's largest shareholders, holding 70,775,255 ordinary shares, representing 7.23% of the company, and valued at £151.5m at the current market price. In addition, funds managed by IP Group continue to hold approximately 11.8 million Oxford Nanopore shares. The Sale proceeds further enhance IP Group's financial flexibility and support the disciplined allocation of capital across the portfolio and broader Group priorities.
Greg Smith, Chief Executive of IP Group, said: "Oxford Nanopore has been one of the standout successes within our portfolio and we remain strong supporters of the company, its management team and its long-term prospects. This transaction represents an appropriate partial realisation of our holding, demonstrating our ability to realise value from maturing portfolio companies while preserving meaningful exposure to future upside. We retain a significant investment in Oxford Nanopore, continue to see substantial long-term potential in the business and look forward to supporting its future development as a major shareholder."
IP Group has entered into a 90-day lock-in undertaking with Joh. Berenberg, Gossler & Co ("Berenberg") with respect to its retained direct holding of 70,775,255 ordinary shares in the Company, subject to certain customary exceptions and/or waiver by Berenberg.
For more information, please contact:
|
IP Group plc |
www.ipgroupplc.com |
|
Liz Vaughan-Adams, Communications |
+44 (0) 20 7444 0062/+44 (0) 7967 312125 |
|
Portland |
|
|
Lewis Bendall-Craft |
+44 (0) 7931 973950 |
Notes for editors
About IP Group
IP Group accelerates the impact of science for a better future. As the most active UK based, early stage science and technology investor, we develop and support some of the world's most exciting businesses in healthtech, deeptech and cleantech. Including through Parkwalk, the UK's largest growth EIS fund manager, we back world-changing innovation emerging in leading universities and research institutions. Our specialist investment team combines sector expertise with an international approach. Together we have a strong track record of success, having backed high-profile companies including Oxford Nanopore Technologies plc, Hinge Health, Featurespace, First Light Fusion, Hysata, and Oxa. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.
For more information, please visit our website at www.ipgroupplc.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.
Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.
This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.
In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.
The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.
Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.
From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.
FOR OUR FULL DISCLAIMER CLICK HERE